Circulation: Cardiovascular Quality & Outcomes

MARCH 28, 2025

BACKGROUND:Although Medicare Advantage (MA) plans provide coverage to >50% of Medicare beneficiaries, it is unclear whether MA claims can be used similarly to Medicare Fee-For-Service (FFS) claims for clinical outcomes assessment. Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.

Medicare 40

Medicare Aortic valve Atrial Flutter Aortic 40

DAIC

MARCH 10, 2025

The real-world patient population analysis, which is the largest dataset of Prevail patients with nearly 1,800 patients, compared the Prevail DCB to other DCBs in a complex patient population, including bifurcations, acute coronary syndrome and diabetes. Prevail DCB is limited to investigational use in the U.S.

Blood Pressure 52

Blood Pressure Aortic Medicare Hypertension 52

Stroke Journal

JANUARY 30, 2025

We longitudinally followed the patients by linking the registry data to the Center for Medicare&Medicaid Service (CMS) claims data. Patients with diabetes (aOR, 95% CI: 2.99, 1.25-7.15) Model fit was assessed using the Hosmer-Lemeshow test.Results:Among 142 eligible pre-ICH statin users (median age [IQR]: 77.5 [72-86]

Medicare 40

Medicare CMS Medicaid Myocardial Infarction 40

CardiacWire

JUNE 30, 2024

GLP-1s are for CVD too – So far this year GLP-1s have gone from a weight loss and diabetes drug that “might” have cardiovascular benefits to becoming an FDA-approved and Medicare-covered option for CV event reduction.

Tricuspid 59

Tricuspid Reimbursement Medicare Electrophysiology 59

CardiacWire

APRIL 10, 2024

GLP-1s Are So Hot Right Now – In the year since ACC 2023, GLP-1s went from a weight loss and diabetes drug that “might” have cardiovascular benefits to becoming a promising (and Medicare-covered) option for CV event reduction.

Innovation 59

Innovation Technology Interventional Cardiology Medicare 59

Stroke Journal

FEBRUARY 1, 2024

Background:Mortality doubles in stroke patients when Diabetes Mellitus (DM) is present. Payer sources were identified as: self-pay, Medicaid, Medicare, and Private/HMO. Differences in compliance rates were 10% for Medicare, 13.5% Stroke, Volume 55, Issue Suppl_1 , Page AWP48-AWP48, February 1, 2024. of patients received AMPB.

Medicaid 40

Medicaid Stroke Strokes Medicare 40

Journal of the American Heart Association

DECEMBER 12, 2023

Factors associated with a higher risk of potentially undiagnosed hypertension included individual characteristics (ages 40–84 compared with 18–39 years), clinical (lack of diabetes diagnosis) and health system factors (clinic site and being a Medicaid versus a Medicare beneficiary), and timing (readings obtained after the COVID‐19 Stay‐At‐Home Order (..)

Hypertension 45

Hypertension COVID-19 Medicaid Medicare 45

DAIC

MARCH 10, 2025

The real-world patient population analysis, which is the largest dataset of Prevail patients with nearly 1,800 patients, compared the Prevail DCB to other DCBs in a complex patient population, including bifurcations, acute coronary syndrome and diabetes. Prevail DCB is limited to investigational use in the U.S.

Blood Pressure 52

Blood Pressure Aortic Medicare Hypertension 52

Stroke Journal

FEBRUARY 1, 2024

vs. 83.8%), and covered by Medicare (91.7% vs. 61.6%), diabetes mellitus (60% vs. 52.2%), tobacco use (37.5% Both groups (PBS vs. no PBS) were predominantly female (59.7% vs. 73.7%), identified as white (76.5% vs. 90.7%). Despite being the most prevalent comorbidity, hypertension (83.6% vs. 36.4%), prior myocardial infarction (12.8%

Obesity 40

Obesity Inpatient Stroke Strokes 40

DAIC

MAY 16, 2024

Risk factors for PAD include smoking; having Type 1 or Type 2 diabetes, high blood pressure, high cholesterol, chronic kidney disease, atherosclerosis in other parts of the body (such as coronary artery disease); and being age 75 years or older. and Global Data From the American Heart Association.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Exercise Ischemia Quality of Life 105

Stroke Journal

FEBRUARY 1, 2024

Medicare) have a lower risk of r-ICH (0.45, 0.31 - 0.67), AIS (0.71, 0.53 - 0.95), and MACE (0.58, 0.47 - 0.71). Patients with lobar ICH (vs. non-lobar ICH) had a higher risk of r-ICH (SHR, CI: 1.67, 1.35 - 2.07) and MACE (1.28, 1.14 - 1.44). Blacks (vs. Whites) have a higher risk of AIS (1.64, 1.32 - 2.03) and MACE (1.42, 1.22 - 1.65).

Hemorrhage 40

Hemorrhage Myocardial Infarction Atrial Fibrillation Medicare 40

Cardiometabolic Health Congress

JANUARY 19, 2024

Short history from development to today’s price hikes Doctors Frederick Banting and Charles Best successfully isolated the hormone insulin just over 100 years ago, dramatically changing the lives of those with diabetes. million Americans with diabetes need to inject insulin to survive, according to the American Diabetes Association.

Diabetes 59

Diabetes Medicare Diet CME 59

Stroke Journal

JANUARY 30, 2025

A logistic regression model was adjusted for age, sex, race, mechanical ventilation, systolic blood pressure, smoking status, diabetes mellitus, atrial fibrillation, hypertension, congestive heart failure, Glasgow Coma Scale, ICH location (side and deep), ICH volume on CT, and presence of intraventricular hemorrhage. 2.03, p=0.022, Figure 1).

Hemorrhage 40

Hemorrhage Medicare Outcomes Medicaid 40

The Beat Blog

MARCH 30, 2022

Her study examined expenditures connected to: CVD medications Office visits Diagnostic procedures Coronary revascularizations Hospitalizations The study’s cost figures were derived from Medicare nationwide and zip-code-specific data that was inflation-corrected, discounted at 3% per year, and presented in 2014 dollars.

Blood Pressure 52

Blood Pressure Diabetes Risk Factors Hypertension 52

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Study Population includes all patients with an ischemic stroke inpatient admission in 2018 and were continuously enrolled with Medicare FFS for 1 year prior to and following their initial 2018 stroke admission. Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. 1.378]), and heart failure (1.282 [95%CI, 1.25‐1.315]).ConclusionPatient

Risk Factors 40

Risk Factors Stroke Strokes Medicare 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Mark Erfe Outcomes of Sutureless/Rapid Deployment Valves Compared to Traditional Bioprosthetic Aortic Valves The Annals of Thoracic Surgery September 2020 J.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Med Page Today

JANUARY 17, 2025

(MedPage Today) -- The blockbuster diabetes and weight-loss drug semaglutide (Ozempic, Rybelsus, Wegovy) along with therapies for asthma, cancers, and various other conditions were among the 15 drugs the Biden administration selected for the next.

Medicare 125

Medicare Cancer Diabetes 125

Dr. S. Venkatesan MD

JANUARY 1, 2025

24 and TCT 2024) Colchicine in AMI CLEAR SYNERGY (OASIS 9) (TCT 2024 and AHA 2024) Semaglutide Treatment Effect in People With Obesity and HFpEF and Diabetes Mellitus STEP-HFpEF DM (ACC.24) Top 10 Clinical Trials Preventive PCI on Stenosis With Functionally Insignificant Vulnerable Plaque PREVENT (ACC.24)

Cardiogenic Shock 59

Cardiogenic Shock Plaque Academic Bicuspid/Mitral 59